AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2001 JAN 18 - (NewsRx.com) -- Women with the sexually transmitted infection Chlamydia trachomatis are at increased risk of developing cervical squamous cell carcinoma (SCC), and the risk is highest when the infection is serotype G, according to an article in the January 3, 2001, issue of the Journal of the American Medical Association (JAMA).
Tarja Anttila, MD, of the National Public Health Institute, Oulu, Finland, and Jorma Paavonen, MD, of the University of Helsinki, and colleagues studied the association between exposure to different Chlamydia trachomatis serotypes and subsequent development of cervical SCC. They conducted a longitudinal, nested case-control study among 530,000 women who provided samples to serum banks in Finland, Norway, and Sweden.
The data files were linked to respective national cancer registries. The study focused on 128 women who developed invasive cervical SCC at least 12 months following serum donation. Each case had three matched controls.
According to the American Medical Association Encyclopedia of Medicine, chlamydiae are a group of microorganisms, intermediate in size between bacteria and viruses, that cause various infectious diseases in humans and animals. Like viruses, they can multiply only by first invading the cells of another life-form; otherwise, they behave more like bacteria than viruses, and are susceptible to treatment with antibiotic drugs. Chlamydia trachomatis and Chlamydia pneumoniae are the two main species of chlamydiae that cause disease in humans. Different strains of C. trachomatis are responsible for various genital, eye, and lymph node infections.
According to background information cited in the study, human papillomavirus (HPV) infection is the leading cause of cervical neoplasia. Additional risk factors include other sexually transmitted infections (STIs) and smoking. Epidemiologic studies suggest that Chlamydia trachomatis infection also confers increased risk for cervical SCC, but whether the risk is serotype-specific has been unknown.
The authors measured serum IgG antibodies to C. trachomatis and Chlamydia pneumoniae. They looked at the risk for development of cervical SCC by IgG antibodies to ten different C. trachomatis serotypes, adjusted for antibodies to HPV types 16, 18, and 33, and for serum cotinine levels to measure tobacco use.
"Of specific C. trachomatis serotypes, serotype G was most strongly associated with SCC [6.6 times increased risk]. Other serotypes associated with SCC were I [3.8 times increased risk] and D [2.7 times increased risk]," the authors wrote. "Exposure to more than one serotype increased the risk for cervical SCC."